
Show Notes
Ralph speaks to Peter Maybarduk of Public Citizen about how the Trump Administration's drug pricing deals favor Big Pharma. Then, some advice for progressive candidates from Ralph and former NYC Public Advocate Mark Green.
Peter Maybarduk directs Public Citizen’s Global Access to Medicines Program, which helps partners worldwide make medicine available and affordable for all. He has provided technical and strategic assistance to government agencies and health organizations in dozens of countries, and sits on the governance board of the Medicines Patent Pool, a United Nations-backed organization that negotiates licenses among drugmakers to expand global availability of affordable generics.
Trump has several different drug pricing initiatives, but he’s hollowing them out himself by negotiating exemptions from his own drug pricing programs on behalf of the Big Pharma corporations. Trump has been signing a series of deals in the White House so far with 27 drug makers, and they get the PR from this, right? They come out and say, “We’ve got a new deal. We’re going to offer the best prices in the world.” But those deals are secret. Part of what we know now is the deals actually exempt the drug makers from any of the binding mandatory programs that Trump is trying to run. Peter Maybarduk
Almost every new drug relies on some kind of US-government funding at some stage. Sometimes it’s just in the research chain (in the literature, the publications) that link back to NIH research. Sometimes it’s all the way up through development…So there’s a lot to be said for public R&D, which already happens. There’s also: we could just manufacture more drugs publicly in the late stage...And generally, if you had, for example, a government-owned-contractor-operated model or a fully public model of production and the proper terms attached to it, you could fight rationing. You could ensure that there’s a basic supply of essential medicines available for people. It would help you fight during pandemics and not have to be reliant on pharma’s profit-maximizing decisions about who is going to get vaccines, for example, at what price and when. You could bring those things under public authority and make them accountable. There’s a lot of levers that we’re not yet using that we could use to make medicine affordable and available for all. Peter Maybarduk
Mark Green is a former Nader’s Raider, who ran Public Citizen’s Congress Watch for ten years and was elected New York City’s first Public Advocate. He’s a prolific author, and has collaborated with Ralph on Fake President: Decoding Trump’s Gaslighting, Corruption, and General B******t, and Wrecking America: How Trump’s Lawbreaking and Lies Betray All. As the GOP spends hundreds of millions on negative ads in the final month, here’s a suggested strategy and narrative for aggressive and progressive Democrats in close contests. First: yes, Assume Trump’s “on the ballot” (in his phrase), to tarnish your rival with his erratic extremism. And second: frame everything under the memorable banner of “Progress, not corruption.” [Trump] has pushed America to an inflection election when voters determine whether Trumpism survives Trump, or whether it becomes a pariah ideology like McCarthyism. Mark Green
News 10/16/26 * Our top story this week is the resounding reelection victory of United Auto Workers President Shawn Fain. As Jacobin reports, Fain won his first term in 2022, taking out the long-entrenched leadership clique at the union following internal democratic reforms, including direct election of union leadership. Under Fain, the UAW has again become a fighting union, winning “record agreements at the Big Three,” automakers following a successful stand-up strike, “delivering 25 percent wage increases, eliminating wage tiers, restoring cost-of-living adjustments, securing bonuses for retirees for the first time in decades, winning the right to strike over product commitments, and bringing electric vehicle batter
More from Ralph Nader Radio Hour
Ralph welcomes Dr. Alison Galvani, the founding director of the Yale Center for Infectious Disease Modeling and Analysis, and co-author of the forthcoming article, “Projected Economic Gains and Lives Saved Under Universal Health Care in the United States.” Then our constitutional law expert, Bruce Fein, stops by to tell us about a letter he and Ralph sent to states Attorneys General urging them to prosecute Donald Trump for exhorting his followers to commit voter fraud in the forthcoming midterm congressional elections. Finally, we respond to your feedback on how to be a smart voter. Alison Galvani is the founding director of the Yale Center for Infectious Disease Modeling and Analysis and the Burnett and Stender Families Professor of Epidemiology at the Yale School of Public Health, Yale School of Medicine. She has applied her modelling and health economics skills to address public health challenges including HIV/AIDS, Zika, Ebola, influenza, and COVID-19. And she is co-author of the forthcoming article “Projected economic gains and lives saved under universal healthcare in the United States.” We analyze the American healthcare system as a national balance sheet. And on one side of the ledger, we have: covering the uninsured and expanding care for the uninsured (that costs money). And we took into account that utilization will increase for people that currently have inadequate health care… And when we initially started looking at this in 2019…I anticipated a hefty price tag as well. Our work has focused on the effectiveness and cost-efficiency of public health policy in the US and around the world, and usually we’re asking: How much will it cost to save lives? And we rarely get a no-brainer where you save money and you’re saving lives. Alison Galvani
Ralph speaks to Dr. Feroze Sidhwa for an update on the death toll in Gaza as well as the new documentary film “American Doctor.” Then Ralph and economic William Lazonick discuss Nvidia’s planned $235 billion stock buyback. Dr. Feroze Sidhwa is a general, trauma, and critical care surgeon in California. He is also a humanitarian surgeon who has worked in Palestine, Ukraine, Haiti, Zimbabwe, and Burkina Faso. He most recently volunteered at Nasser Medical Complex in Khan Younis, Gaza. He was blocked from entering Gaza by Israel’s Shin Bet intelligence service in November 2025. His work in Gaza is featured in the new documentary film American Doctor. If I’m remembering the exact time right, March of 2016 was the deadliest month for children that [Airwars] had ever studied anywhere—so that’s the 31 days of March of 2016. In the first 25 days of the US-Israeli assault on Gaza, the rate of killing of children was 71 to 142 times higher than in the deadliest month they had ever studied for children anywhere else. And just to put these numbers in a little bit of perspective…If you look at Russia’s invasion of Ukraine versus Israel’s invasion of Gaza, Russian forces killed the same percentage of children in Ukraine in 10 months as the US and Israel kill in Gaza every 18 to 37 hours. Dr. Feroze Sidhwa
Ralph welcomes Mary Berry the daughter of the late American novelist, poet, essayist, environmental activist, cultural critic, and farmer, Wendell Berry. Ms. Berry runs the non-profit Berry Center in New Castle, Kentucky, which serves as a repository for the study of small farm agriculture and preserves the legacy of her family’s work. Then, with the midterms on the horizon, Ralph and the team talk about how to be a smart voter. Plus, Ralph has some choice words for the U.S. Chamber of Commerce’s so-called “Free Enterprise Express.” Leave a comment about how you are a smart voter. We will collect these and discuss them on our next program. Click the button below to get Professor Laura Nader’s book Controlling Processes.
Ralph welcomes “New York Times” reporter Natasha Singer to discuss her new book, “Coding Kids: Big Tech’s Battle to Remake Public Schools.” Then, Ralph talks about Donald Trump’s midterm convention speeches and the latest impeachment drive with Constitutional law expert Bruce Fein. Natasha Singer is a New York Times reporter covering the intersection of technology, business and education. She has covered tech industry influence in schools for the New York Times for more than a decade, and her school tech reporting helped prompt California to enact a landmark student online data protection law. In 2019, she was part of a Times team whose tech coverage won a George Polk Award and was a Pulitzer Prize finalist for National Reporting. She is also the author of the book Coding Kids: Big Tech’s Battle to Remake Public Schools. It’s not about the companies immediately making money off schools. It’s about influencing kids, getting customers early and for life. But I think more importantly, it’s about imprinting Silicon Valley worldviews and values on young people. So that you get docile consumers who maybe aren’t worried about wholesale surveillance and data gathering, and docile employees who are not going to push back against being surveilled by their employer or using AI tools or having AI replace them. And so I think this story about tech companies capturing the classroom is not just about how they’re shaping learning. It’s about how some of the most powerful, wealthiest corporations on the planet are able to influence school systems. Natasha Singer
Ralph welcomes Keira Havens a United States Air Force veteran and the executive director of Citizens’ Impeachment a grassroots organization that lobbies Congress and supports candidates who are willing to impeach and convict Donald Trump for a myriad of Constitutional violations. Then Michael Marx, founder of the group CorpEthics that conducts marketing campaigns that apply public pressure to corporations to change their behavior, joins us to discuss his new book “Reining in the Bulls: How to Stop Corporate Abuse in an Age of Unbridled Greed.” Keira Havens is a United States Air Force veteran, a former scientist, and a longtime political activist. She is the executive director of Citizens’ Impeachment. I am a veteran. I was in the United States Air Force. My job was to launch nuclear missiles. I was an ICBM crew commander for four years. And that entire system, that entire weapons system is based on trust that the person at the top has a handle on what needs to be done and has good faith and good leadership to navigate this country. That is not the case right now. That cornerstone is beyond weakened—it has just crumbled straight into dust. The trust and faith in the American President as a capable leader, capable of effective leadership, is an assumption we can no longer make. Keira Havens